EMA considers next steps after annulment of Guido Rasi appointment

The management board of the European Medicines Agency held an extraordinary meeting last month in Rome, Italy, to discuss the consequences of the judgment by the European Union Civil Service Tribunal that annulled the appointment of the Agency’s executive director Guido Rasi (The Pharma Letter November 14).

The board, chaired by Sir Kent Woods, confirmed that deputy executive director Andreas Pott will be in charge of the management and operations of the EMA until the new selection procedure suggested by the European Commission is finalized. The European Commission plans to publish a vacancy announcement for the post of executive director shortly.

Sir Kent Woods was asked to explore how Guido Rasi can best support the Agency in the coming months as his contract is in operation.